Country Reports

Squirreled away right on the South-Eastern fringe of Europe, Bulgaria still has a tendency to be overlooked and underestimated by the uninitiated. Not so by the international pharmaceuticals industry, however, which has long considered what is one of the EU’s most recent member states to be a comparatively uncomplicated and hospitable place for doing business;…

Transitioning out of a period of instability following the revolution of 2011, Tunisia has much to recommend it within its region. Comparative political stability and a geostrategic location as the northerly most country in Africa are helping turn the Arab world’s only full democracy into an attractive investment destination once again.   In terms of…

This report offers companies, investors, policymakers, and stakeholders crucial insight into the ecosystem of pharmaceutical companies in Ukraine, based on in-depth interviews conducted with leaders and pioneers across the value chain, from government representatives, the international organizations now in charge of Ukraine’s public procurement, country managers of the leading MNCs that have remained in Ukraine,…

With steady GDP growth, political stability and the best healthcare system in Latin America, Colombia’s life sciences industry has all the ingredients for success laid out before it. Indeed, with the domestic pharmaceutical market set to grow at a rate of around 7.3 percent and reach a USD 7.1 billion valuation by 2020, coupled with…

This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies in Hong Kong, based on in-depth interviews conducted with leaders and pioneers across the value chain, from government representatives, country managers of the world’s leading biopharmaceutical companies, representatives from local SMEs and service providers, and…

This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies in Indonesia, based on in-depth interviews conducted with leaders and pioneers across the value chain, from the Ministries of Health and Industry, the leaders of the Indonesian public procurement and social security institutes, country managers…

Meanwhile the country’s newly appointed minister of health has been audacious in radically reshuffling the rules of the game to place public healthcare provision “firmly on a pathway to sustainability.” “A corner has been turned and we are well on the way to establishing the enabling environment for an enduring healthcare system that is viable…

This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies on Taiwan, based on in-depth interviews conducted with leaders and pioneers across the value chain, from government representatives, global affiliate heads, and founders of innovative local SMEs. While Taiwan’s remarkable economic growth has largely been…

This report offers companies, investors, policymakers, and stakeholders crucial insight into Switzerland; a country  located at the heart of Europe, home to some of the world’s most important international health institutions as well as two of its largest pharmaceutical companies in Novartis and Roche, and with a number one ranking globally in terms of ease…

This report offers companies, investors, policymakers, and stakeholders crucial insight into Greece; a country with an admirable and long-standing history in healthcare and pharmaceuticals, but one that is still struggling to find its way out of a national debt crisis. The interviewees from government, associations, MNCs and local players featured in the report discuss the…

This report offers companies, investors, policymakers, and stakeholders crucial insight into five companies at the cutting edge of Taiwan’s biotech industry: PharmaEngine, PharmaEssentia, OBI Pharma, SyneuRx, and TaiGen Biotechnology. The report features in-depth exclusive interviews with the heads of these pioneering organizations, facts and figures on the companies’ market capitalizations, therapeutic areas, and product pipelines,…

This report offers companies, investors, policymakers, and stakeholders crucial insight into Ireland; a nation that stands poised to cement its position as a premier pharmaceuticals power, not just within Europe, but globally. In addition to its blossoming R&D infrastructure, a large number of major healthcare, pharma, and medtech MNCs base manufacturing operations on the Emerald…